Robotic surgery in liver, biliary tract and pancreas

As demonstrating the annual case numbers of robotic surgery in each field, it is simple to explain that with improved technology and accumulated experience, minimal invasive surgery will no longer be contraindicated for cancer at liver, biliary tract and pancreas. The flexible movement of the robot contributes to better vision, greater precision in dissection, and vascular control, which may probably result in better oncologic outcome, sooner post-operative recovery and a shorter learning curve than the laparoscopy method. We will show several surgery clips to disclose the difference between laparoscopic and robotic method, and the stability and endurance will be quite a gap. Moreover, the posture for the surgeon is also much more friendly when sitting in the console, which may protect our spines and intervertebral discs and prolong the career life. In conclusion, this is the era of robotic surgery and there are still many challenges to concur. We should try to apply such good tool for every kind of surgery. As for the platform of robotic surgery, current world is mainly seized by the da Vinci system, but more the options might create different sparkles.